ES489220A0 - Un procedimiento para la preparacion de derivados del indol. - Google Patents

Un procedimiento para la preparacion de derivados del indol.

Info

Publication number
ES489220A0
ES489220A0 ES489220A ES489220A ES489220A0 ES 489220 A0 ES489220 A0 ES 489220A0 ES 489220 A ES489220 A ES 489220A ES 489220 A ES489220 A ES 489220A ES 489220 A0 ES489220 A0 ES 489220A0
Authority
ES
Spain
Prior art keywords
inol
derivatives
procedure
preparation
inol derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES489220A
Other languages
English (en)
Other versions
ES8104278A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Pfizer Inc
Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp, Pfizer Inc filed Critical Pfizer Corp
Publication of ES8104278A1 publication Critical patent/ES8104278A1/es
Publication of ES489220A0 publication Critical patent/ES489220A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES489220A 1979-03-07 1980-03-05 Un procedimiento para la preparacion de derivados del indol. Granted ES489220A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7908123 1979-03-07

Publications (2)

Publication Number Publication Date
ES8104278A1 ES8104278A1 (es) 1981-04-01
ES489220A0 true ES489220A0 (es) 1981-04-01

Family

ID=10503707

Family Applications (2)

Application Number Title Priority Date Filing Date
ES489220A Granted ES489220A0 (es) 1979-03-07 1980-03-05 Un procedimiento para la preparacion de derivados del indol.
ES496889A Granted ES496889A0 (es) 1979-03-07 1980-11-14 Un procedimiento para la preparacion de derivados del indol

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES496889A Granted ES496889A0 (es) 1979-03-07 1980-11-14 Un procedimiento para la preparacion de derivados del indol

Country Status (36)

Country Link
US (1) US4273782A (es)
JP (1) JPS55133380A (es)
KR (1) KR850000760B1 (es)
AR (1) AR227015A1 (es)
AT (1) AT375366B (es)
AU (1) AU516957B2 (es)
BE (1) BE882113A (es)
CA (1) CA1120479A (es)
CH (1) CH649546A5 (es)
CS (1) CS253702B2 (es)
DD (1) DD149525A5 (es)
DE (1) DE3008632A1 (es)
DK (1) DK151884C (es)
ES (2) ES489220A0 (es)
FI (1) FI66860C (es)
FR (1) FR2450832A1 (es)
GR (1) GR67237B (es)
HK (1) HK89884A (es)
HU (1) HU184727B (es)
IE (1) IE49542B1 (es)
IL (1) IL59524A (es)
IT (1) IT1218420B (es)
KE (1) KE3467A (es)
LU (1) LU82224A1 (es)
MY (1) MY8500285A (es)
NL (1) NL182959C (es)
NO (1) NO152217C (es)
NZ (1) NZ193052A (es)
PH (1) PH15198A (es)
PL (1) PL128296B1 (es)
PT (1) PT70914A (es)
SE (1) SE440778B (es)
SG (1) SG67284G (es)
SU (1) SU1277894A3 (es)
YU (1) YU41911B (es)
ZA (1) ZA801328B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414159A (en) * 1980-09-26 1983-11-08 E. I. Du Pont De Nemours & Co. Vinyl ether monomers and polymers therefrom
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
KR840000529A (ko) * 1981-07-07 1984-02-25 콘스탄틴 루이스 클레멘트 인돌 유도체의 제조방법
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4539410A (en) * 1982-09-30 1985-09-03 Ciba-Geigy Corporation N-Substituted-2-(1-imidazolyl)indoles
US4436746A (en) 1982-09-30 1984-03-13 Ciba-Geigy Corporation Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
AT376436B (de) * 1982-11-05 1984-11-26 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
ATE90076T1 (de) 1986-03-27 1993-06-15 Merck Frosst Canada Inc Tetrahydrocarbazole ester.
JPH0832679B2 (ja) * 1986-09-05 1996-03-29 理化学研究所 Ｎ―フタルイシド誘導体及びその製造法
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
EP0427860A1 (en) * 1989-03-31 1991-05-22 Kyoto Pharmaceutical Industries, Ltd. New imidazole derivatives, production thereof, and uses thereof as medicines
DE4023215A1 (de) * 1990-07-21 1992-01-23 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
KR930702334A (ko) * 1990-09-13 1993-09-08 데이비드 로버트 5 하이드록시트립타민 수용체 길항제로서의 인돌우레아
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5120749A (en) * 1991-02-20 1992-06-09 Abbott Laboratories Platelet activating antagonists
IL104125A (en) * 1991-12-18 2000-08-31 Schering Corp Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring and pharmaceutical compositions comprising them
WO1993020065A1 (en) * 1992-03-27 1993-10-14 Kyoto Pharmaceutical Industries, Ltd. Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
JPH0632913U (ja) * 1992-09-18 1994-04-28 三洋電機株式会社 床暖房用パネル
ID27884A (id) * 1998-03-31 2001-05-03 Inst For Pharm Discovery Inc Asam-asam indolealkanoat yang disubstitusikan.
JP2006514640A (ja) * 2002-12-10 2006-05-11 ワイス プラスミノゲンアクティベータインヒビターのインヒビターとしての置換３−アルキル及び３−アリールアルキル１ｈ−イル酢酸誘導体
GB0324763D0 (en) * 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
NZ554491A (en) * 2004-10-12 2009-07-31 Decode Genetics Ehf Sulfonamide peri-substituted bicyclics for occlusive artery disease
AU2006283104A1 (en) * 2005-08-25 2007-03-01 Pharmacopeia, Inc. Imidazole derivatives as functionally selective alpha2C adrenoreceptor agonists
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) * 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
RU2008149518A (ru) * 2006-05-16 2010-06-27 Декод Дженетикс, Ехф. (Is) Способ получения 7-(акрилоил) индолов
RU2458918C2 (ru) 2006-07-22 2012-08-20 Оксаген Лимитед Соединения, обладающие антагонистической активностью по отношению к crth2
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
AU2008350907A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
EP2250161B1 (en) 2008-01-18 2013-10-16 Atopix Therapeutics Limited Compounds having crth2 antagonist activity
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
WO2009093029A1 (en) * 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
US20100022613A1 (en) * 2008-01-22 2010-01-28 Oxagen Limited Compounds Having CRTH2 Antagonist Activity
AU2009325091A1 (en) * 2008-05-23 2010-06-17 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein inhibitor
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
EP2739144A4 (en) * 2011-06-20 2015-04-01 Alzheimer S Inst Of America Inc COMPOUNDS AND ITS THERAPEUTIC USE
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
US11530186B2 (en) * 2018-03-29 2022-12-20 H. Lee Moffitt Cancer Center and Research Center Institute, Inc. Inhibitors for the β-catenin / T-cell factor protein-protein interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (es) * 1963-06-06
US3370063A (en) * 1964-10-05 1968-02-20 Mcneilab Inc Substituted dimethoxy indoles and method of making the same
US3621027A (en) * 1968-03-18 1971-11-16 Endo Lab 1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
US3931229A (en) * 1973-08-23 1976-01-06 Warner-Lambert Company 3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4059583A (en) * 1975-11-13 1977-11-22 Mcneil Laboratories, Incorporated Substituted indoles
GR66544B (es) * 1977-08-26 1981-03-26 Wellcome Found
US4140858A (en) * 1977-12-19 1979-02-20 Warner-Lambert Company 3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
DE2960547D1 (en) * 1978-02-24 1981-11-05 Pfizer Ltd 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

Also Published As

Publication number Publication date
KE3467A (en) 1984-11-09
HU184727B (en) 1984-10-29
IE49542B1 (en) 1985-10-30
HK89884A (en) 1984-11-23
DE3008632C2 (es) 1988-02-25
US4273782A (en) 1981-06-16
YU61480A (en) 1983-12-31
JPS6141513B2 (es) 1986-09-16
PL222470A1 (es) 1980-12-01
ES8104278A1 (es) 1981-04-01
ATA125780A (de) 1983-12-15
AT375366B (de) 1984-07-25
PH15198A (en) 1982-09-17
SU1277894A3 (ru) 1986-12-15
CH649546A5 (de) 1985-05-31
LU82224A1 (fr) 1980-06-06
CS253702B2 (en) 1987-12-17
SG67284G (en) 1985-03-15
IT1218420B (it) 1990-04-19
MY8500285A (en) 1985-12-31
AR227015A1 (es) 1982-09-15
FI66860B (fi) 1984-08-31
ES8205789A1 (es) 1982-08-01
FR2450832B1 (es) 1983-04-22
AU5623180A (en) 1980-09-11
AU516957B2 (en) 1981-07-02
SE440778B (sv) 1985-08-19
DK151884C (da) 1988-06-13
GR67237B (es) 1981-06-25
PT70914A (en) 1980-04-01
NL182959C (nl) 1988-06-16
IE800453L (en) 1980-09-07
KR830001928A (ko) 1983-05-19
NO152217C (no) 1985-08-21
SE8001736L (sv) 1980-09-08
NZ193052A (en) 1984-07-06
NO152217B (no) 1985-05-13
NO800650L (no) 1980-09-08
ES496889A0 (es) 1982-08-01
YU41911B (en) 1988-02-29
CA1120479A (en) 1982-03-23
IL59524A (en) 1982-11-30
IT8020399A0 (it) 1980-03-06
FI800672A (fi) 1980-09-08
DE3008632A1 (de) 1980-10-16
KR850000760B1 (ko) 1985-05-25
IL59524A0 (en) 1980-06-30
DK151884B (da) 1988-01-11
PL128296B1 (en) 1984-01-31
BE882113A (fr) 1980-09-08
FI66860C (fi) 1984-12-10
DD149525A5 (de) 1981-07-15
NL8001351A (nl) 1980-09-09
JPS55133380A (en) 1980-10-17
DK42580A (da) 1980-09-08
ZA801328B (en) 1981-03-25
FR2450832A1 (fr) 1980-10-03

Similar Documents

Publication Publication Date Title
ES489220A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES545810A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES508453A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxiquinazolina.
ES497304A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilamino-fluorano.
ES504695A0 (es) Un procedimiento para la preparacion de un derivado del indol.
ES507715A0 (es) Procedimiento para preparar derivados de 1-sulfo-2-oxoazetidina .
ES507126A0 (es) Procedimiento para preparar derivados de piridona.
ES508618A0 (es) Procedimiento para la preparacion de derivados de la quino- lina.
ES487843A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES513933A0 (es) Un procedimiento para la preparacion de un derivado del indol.
ES513934A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES488886A0 (es) Un procedimiento para la preparacion de derivados acidos penemcarboxilicos.
ES494853A0 (es) Un procedimiento para la preparacion de derivados de etanol-amina.
ES495586A0 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
ES495163A0 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES492666A0 (es) Un procedimiento para la preparacion de derivados del 2,3- dihidro-5- acilbenzofuranos 2,6,7- trisustituidos.
ES513765A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES479490A0 (es) Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
ES490722A0 (es) Un procedimiento para la preparacion de nuevos derivados de piridazina.
ES498017A0 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ES494291A0 (es) Procedimiento para la preparacion de derivados diazoicos.
ES489184A0 (es) Procedimiento para la produccion de derivados de feobromina.
ES495589A0 (es) Un procedimiento para la preparacion de derivados de imida- lol.
ES495932A0 (es) Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.
ES494546A0 (es) Un procedimiento para la preparacion de derivados del pirrol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612